RE:End of 2022Genie29j wrote: Well, it's been another brutal year. Replicel closed at 5¢ to end the 2022 year.
While this is certainly another blow to our "investment", I trust that Andrew and the outcome of the Shiseido trial are our last two hurrahs.. both will have a runway of about 8 months.
Nervous? Thoughts?
let's hope we end 2023 on a better note! Here's to a year end close price of $3-4.00
Cheers
Yes, let's hope that 2023 is the year that us long term investors finally see the return we have been patiently waiting for.
I re-read the Corporate Update from late November and in it are some interesting forshadowing.
Under Financing:
"RepliCel remains in talks with multiple investors, current and new, and is witnessing increased interest."
This latest tweet from Dec. 19th:
"We just arrived in Japan! We are meeting with multiple potential investors and partners for all of our products."
For Andrew Schutte to fly to Japan there must be a strong probability of landing a major investor. What type of investor ? Strictly injecting money for shares or possibly a much larger investor interested in taking on RCH-01 in the eventuality that Replicel wins the Arbitration with Shiseido.This new "mega" investor may also want to be the distributor for Dermaprecise in Japan.
Yes my imagination is running wild but who knows. I imagine that over the next week there will be some sort of update on this trip to Japan.